Growing focus on gene-based therapies, advances in editing tools, and increasing research investments are accelerating the adoption of genome editing technologies across life sciences and agriculture.
Hyderabad, India, Jan. 20, 2026 (GLOBE NEWSWIRE) — According to Mordor Intelligence, the genome editing market size was valued at USD 10.60 billion in 2025 and projected to grow from USD 12.29 billion in 2026 to surpass USD 25.74 billion by 2031, at a CAGR of 15.98% during the forecast period (2026-2031). The market growth is supported by rising adoption in biomedical research, therapeutic development, and agricultural biotechnology. Genome editing technologies are increasingly being used by pharmaceutical and biotechnology companies, academic research institutes, and contract research organizations to enable precise genetic modifications, improve research efficiency, and accelerate product development timelines.
The genome editing market is being shaped by expanding applications in gene therapy, oncology research, rare genetic disorder studies, and crop improvement programs. Continuous advancements in editing platforms such as CRISPR-based systems, TALENs, and ZFNs are improving accuracy, scalability, and usability, thereby supporting broader adoption. In addition, increasing public and private funding for genomics research and growing collaboration between academic institutions and industry players are contributing to the genome editing market growth.
Genome Editing Market Regional Share Analysis
North America represents a major share of the genome editing industry, driven by a strong biotechnology ecosystem, advanced research infrastructure, and high investment in genomics and gene therapy research. The region continues to see widespread adoption of genome editing tools across academic, clinical, and commercial research settings.
Europe holds a significant genome editing market share, supported by active research initiatives, growing focus on precision medicine, and increasing use of genome editing in agricultural and biomedical applications. Asia-Pacific is emerging as a high-growth region, fueled by expanding biotechnology capabilities, increasing government support for life sciences research, and rising adoption of advanced genetic technologies in countries across the region.
Genome Editing Market Trends & Forecast
Rising Use of Genome Editing in Therapeutic Research
Genome editing is increasingly being applied in therapeutic research areas such as oncology, rare genetic diseases, and infectious disorders. Researchers are utilizing advanced editing tools to improve target specificity and accelerate preclinical and clinical research efforts.
Expansion of Genome Editing in Agricultural Biotechnology
The use of genome editing in agriculture is expanding as companies and research institutions focus on developing crops with improved yield, resistance to pests, and tolerance to environmental stress. This application area continues to support long-term market growth.
Genome Editing Industry Segmentation Overview
By Technology
- Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)
- Transcription Activator-Like Effector Nuclease (TALEN)
- Zinc Finger Nuclease (ZFN)
- Meganucleases
- Oligonucleotide-directed Mutagenesis (ODM)
- Other Technologies
By Delivery Method
- Viral Vectors
- Non-viral Physical Methods
- Non-viral Chemical Methods
By Application
- Cell Line Engineering
- Gene & Cell Therapy
- Drug Discovery & Functional Genomics
- Agricultural Crop Engineering
- Diagnostics & Synthetic Biology
By End User
- Pharmaceutical & Biotechnology Companies
- Academic & Government Research Institutes
- Contract Research Organizations
- Agriculture & Food Companies
By Geography
- North America
- Europe
- Asia-Pacific
- Middle East & Africa
- South America
For a full breakdown of market dynamics, segmentation insights, regional analysis, and competitive landscape, access the details of the Mordor Intelligence report: https://www.mordorintelligence.com/industry-reports/genome-editing-market?utm_source=globenewswire
Genome Editing Market Competitive Outlook
The genome editing industry consists of a mix of established biotechnology companies and specialized genome engineering firms. Market participants are focusing on technology enhancement, expanding application areas, and forming strategic collaborations to strengthen their presence across research and commercial markets.
- GenScript USA Inc.
- Integrated DNA Technologies Inc.
- New England Biolabs Inc.
- Sangamo Biosciences Inc.
- Thermo Fisher Scientific Inc.
- GenScript Biotech Corporation
Check out related reports published by Mordor Intelligence
Cell-free Protein Expression Market: The cell-free protein expression market report is segmented by products (accessories & consumables, lysate systems), expression method (coupled transcription and translation, translation), application (enzyme engineering), end-user (pharmaceutical & biotechnology companies, academic & research institutes), and geography (North America).
Thermo Fisher Scientific Inc., Promega Corporation, Merck KGaA (Sigma-Aldrich), Takara Bio Inc. and New England Biolabs are the major companies operating in this market.
Read more about companies active in Cell-Free Protein Expression: https://www.mordorintelligence.com/industry-reports/cell-free-protein-expression-market/companies?utm_source=globenewswire
Nutrigenomics Market: The nutrigenomics market is segmented by application (cardiovascular diseases, obesity), product (diagnostic kits and reagents, and nutrition {vitamins & minerals}), end-user (hospitals & clinics, research institutes), distribution channel (direct to consumer), and geography (North America, Europe).
BASF SE, Danone, Cell-Logic, DSM, and Metagenics Inc. are the major companies operating in this market.
Read more about companies active in Nutrigenomics: https://www.mordorintelligence.com/industry-reports/nutrigenomics-market/companies?utm_source=globenewswire
Synthetic Biology Market: The global synthetic biology market report is segmented by product (core products, enabling products, and enabled products), application (healthcare, chemicals (including biofuels), food and agriculture, and other applications (biosecurity, energy, and environment)), and geography (North America, Europe, Asia-Pacific, Middle East and Africa, and South America).
Genscript, Thermo Fisher Scientific, Amyris, Integrated DNA Technologies, and Illumina are the major companies operating in this market.
Read more about companies active in Synthetic Biology: https://www.mordorintelligence.com/industry-reports/synthetic-biology-market/companies?utm_source=globenewswire
About Mordor Intelligence:
Mordor Intelligence is a trusted partner for businesses seeking comprehensive and actionable market intelligence. Our global reach, expert team, and tailored solutions empower organizations and individuals to make informed decisions, navigate complex markets, and achieve their strategic goals.
With a team of over 550 domain experts and on-ground specialists spanning 150+ countries, Mordor Intelligence possesses a unique understanding of the global business landscape. This expertise translates into comprehensive syndicated and custom research reports covering a wide spectrum of industries, including aerospace & defense, agriculture, animal nutrition and wellness, automation, automotive, chemicals & materials, consumer goods & services, electronics, energy & power, financial services, food & beverages, healthcare, hospitality & tourism, information & communications technology, investment opportunities, and logistics.
CONTACT: For any inquiries, please contact: media@mordorintelligence.com https://www.mordorintelligence.com/contact-us
Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. IndiaShorts takes no editorial responsibility for the same.
